HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study

BMC Public Health

Table 5 Multivariate correlates to being “very likely” to receive an HIV vaccine (n = 432) ^a

Characteristic	AOR (95% CI)	p-value
Demographic
Male	0.33 (0.21 - 0.52)	<0.001^**
Age	1.00 (0.98 – 1.03)	0.872
Behavioral (past 6 months)
Injected drugs	1.25 (0.70– 2.26)	0.453
Injected drugs with unclean needle	0.80 (0.29 – 2.20)	0.659
Bleached injection equipment	1.05 (0.39 – 2.82)	0.925
Unprotected sex with PWID	1.42 (0.72 – 2.80)	0.312
Attitudes
Perceived severity of HIV	0.67 (0.11 – 4.07)	0.664
Perceived susceptibility to HIV²	2.31(1.28 – 4.16)	0.006^**
Perceived benefits	2.80 (1.70 – 4.64)	<0.001^**
Perceived barriers	0.62 (0.32 - 1.23)	0.175
Experiential attitude	1.85 (1.08 – 3.17)	0.025^*
Subjective norms
Descriptive norms	1.17 (0.70 – 1.95)	0.552
Injunctive norms	1.81 (1.09 – 3.01)	0.023^*
Agency
Perceived behavioral control	1.25 (0.77 – 2.01)	0.363
Self-efficacy	1.27 (0.65 – 2.52)	0.485

PWID: person who injects drugs; AOR: adjusted odds ratio; CI: confidence interval.
*p < 0.05; ^**p < 0.01.
^aData on norms were missing for one participant resulting in the inclusion of 432 in the analysis.

ISSN: 1471-2458